Cochlear sparing via intensity modulated radiotherapy

Bookmark and Share
Published: 6 Jun 2016
Views: 1188
Dr Chris Nutting - Royal Marsden Hospital, London, UK

Dr Nutting meets with ecancertv at ASCO 2016 to share the results from a multicentre trial which sought to determine if hearing loss associated with parotid cancer radiotherapy could be spared via intensity modulation.

He reports that the trial failed to spare hearing loss as hoped, but they will take these results forward to establish safe levels in further trials.